Literature DB >> 26084024

E3 Ubiquitin Ligase VHL Regulates Hypoxia-Inducible Factor-1α to Maintain Regulatory T Cell Stability and Suppressive Capacity.

Jee H Lee1, Chris Elly1, Yoon Park1, Yun-Cai Liu2.   

Abstract

Foxp3(+) regulatory T (Treg) cells play a critical role in immune homeostasis; however, the mechanisms to maintain their function remain unclear. Here, we report that the E3 ubiquitin ligase VHL is essential for Treg cell function. Mice with Foxp3-restricted VHL deletion displayed massive inflammation associated with excessive Treg cell interferon-γ (IFN-γ) production. VHL-deficient Treg cells failed to prevent colitis induction, but converted into Th1-like effector T cells. VHL intrinsically orchestrated such conversion under both steady and inflammatory conditions followed by Foxp3 downregulation, which was reversed by IFN-γ deficiency. Augmented hypoxia-inducible factor 1α (HIF-1α)-induced glycolytic reprogramming was required for IFN-γ production. Furthermore, HIF-1α bound directly to the Ifng promoter. HIF-1α knockdown or knockout could reverse the increased IFN-γ by VHL-deficient Treg cells and restore their suppressive function in vivo. These findings indicate that regulation of HIF-1α pathway by VHL is crucial to maintain the stability and suppressive function of Foxp3(+) T cells.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26084024      PMCID: PMC4498255          DOI: 10.1016/j.immuni.2015.05.016

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  41 in total

Review 1.  Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors.

Authors:  Michail Sitkovsky; Dmitriy Lukashev
Journal:  Nat Rev Immunol       Date:  2005-09       Impact factor: 53.106

2.  Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase.

Authors:  T Kamura; D M Koepp; M N Conrad; D Skowyra; R J Moreland; O Iliopoulos; W S Lane; W G Kaelin; S J Elledge; R C Conaway; J W Harper; J W Conaway
Journal:  Science       Date:  1999-04-23       Impact factor: 47.728

3.  Metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically BAFF-exposed B cells.

Authors:  Alfredo Caro-Maldonado; Ruoning Wang; Amanda G Nichols; Masayuki Kuraoka; Sandra Milasta; Lillian D Sun; Amanda L Gavin; E Dale Abel; Garnett Kelsoe; Douglas R Green; Jeffrey C Rathmell
Journal:  J Immunol       Date:  2014-03-10       Impact factor: 5.422

Review 4.  Cancer's molecular sweet tooth and the Warburg effect.

Authors:  Jung-whan Kim; Chi V Dang
Journal:  Cancer Res       Date:  2006-09-15       Impact factor: 12.701

5.  p66Shc is involved in promoting HIF-1alpha accumulation and cell death in hypoxic T cells.

Authors:  Fabio Carraro; Annalisa Pucci; Michela Pellegrini; Pier Giuseppe Pelicci; Cosima T Baldari; Antonella Naldini
Journal:  J Cell Physiol       Date:  2007-05       Impact factor: 6.384

Review 6.  Hypoxia-inducible factor 1 (HIF-1) pathway.

Authors:  Gregg L Semenza
Journal:  Sci STKE       Date:  2007-10-09

7.  Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa.

Authors:  Eric T Clambey; Eóin N McNamee; Joseph A Westrich; Louise E Glover; Eric L Campbell; Paul Jedlicka; Edwin F de Zoeten; John C Cambier; Kurt R Stenmark; Sean P Colgan; Holger K Eltzschig
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-17       Impact factor: 11.205

8.  Targeting the von Hippel-Lindau E3 ubiquitin ligase using small molecules to disrupt the VHL/HIF-1α interaction.

Authors:  Dennis L Buckley; Inge Van Molle; Peter C Gareiss; Hyun Seop Tae; Julien Michel; Devin J Noblin; William L Jorgensen; Alessio Ciulli; Craig M Crews
Journal:  J Am Chem Soc       Date:  2012-02-27       Impact factor: 15.419

9.  Notch1 is required for hypoxia-induced proliferation, invasion and chemoresistance of T-cell acute lymphoblastic leukemia cells.

Authors:  Jie Zou; Peng Li; Fei Lu; Na Liu; Jianjian Dai; Jingjing Ye; Xun Qu; Xiulian Sun; Daoxin Ma; Jino Park; Chunyan Ji
Journal:  J Hematol Oncol       Date:  2013-01-05       Impact factor: 17.388

10.  Development of lymphoproliferative diseases by hypoxia inducible factor-1alpha is associated with prolonged lymphocyte survival.

Authors:  Eisaburo Sueoka; Naoko Sueoka-Aragane; Akemi Sato; Masaru Ide; Hideaki Nakamura; Yusuke Sotomaru; Choji Taya; Hiromichi Yonekawa; Tomoyuki Kitagawa; Yasushi Kubota; Shinya Kimura; Kei Nakachi; Keiji Tanimoto
Journal:  PLoS One       Date:  2013-04-12       Impact factor: 3.240

View more
  82 in total

Review 1.  Harnessing the plasticity of CD4(+) T cells to treat immune-mediated disease.

Authors:  Michel DuPage; Jeffrey A Bluestone
Journal:  Nat Rev Immunol       Date:  2016-02-15       Impact factor: 53.106

Review 2.  Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia.

Authors:  Muhammad Zaeem Noman; Meriem Hasmim; Yosra Messai; Stéphane Terry; Claudine Kieda; Bassam Janji; Salem Chouaib
Journal:  Am J Physiol Cell Physiol       Date:  2015-08-26       Impact factor: 4.249

3.  Glutaminase 1 Inhibition Reduces Glycolysis and Ameliorates Lupus-like Disease in MRL/lpr Mice and Experimental Autoimmune Encephalomyelitis.

Authors:  Michihito Kono; Nobuya Yoshida; Kayaho Maeda; Abel Suárez-Fueyo; Vasileios C Kyttaris; George C Tsokos
Journal:  Arthritis Rheumatol       Date:  2019-09-27       Impact factor: 10.995

Review 4.  IFN-γ: A cytokine at the right time, is in the right place.

Authors:  J Daniel Burke; Howard A Young
Journal:  Semin Immunol       Date:  2019-06-17       Impact factor: 11.130

5.  A PHD in immunosuppression: oxygen-sensing pathways regulate immunosuppressive Tregs.

Authors:  Weiping Zou; Yatrik M Shah
Journal:  J Clin Invest       Date:  2019-07-29       Impact factor: 14.808

Review 6.  Ubiquitin Ligases in Cancer Immunotherapy - Balancing Antitumor and Autoimmunity.

Authors:  Yu Fujita; Roberto Tinoco; Yan Li; Daniela Senft; Ze'ev A Ronai
Journal:  Trends Mol Med       Date:  2019-03-18       Impact factor: 11.951

Review 7.  Mitochondrial control of immunity: beyond ATP.

Authors:  Manan M Mehta; Samuel E Weinberg; Navdeep S Chandel
Journal:  Nat Rev Immunol       Date:  2017-07-03       Impact factor: 53.106

Review 8.  Treg Fragility: A Prerequisite for Effective Antitumor Immunity?

Authors:  Abigail E Overacre-Delgoffe; Dario A A Vignali
Journal:  Cancer Immunol Res       Date:  2018-08       Impact factor: 11.151

Review 9.  HIF1α and metabolic reprogramming in inflammation.

Authors:  Sarah E Corcoran; Luke A J O'Neill
Journal:  J Clin Invest       Date:  2016-08-29       Impact factor: 14.808

Review 10.  Hypoxia-dependent regulation of inflammatory pathways in immune cells.

Authors:  Cormac T Taylor; Glen Doherty; Padraic G Fallon; Eoin P Cummins
Journal:  J Clin Invest       Date:  2016-07-25       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.